Transform insight into action today
Connect with our team to tackle your toughest life sciences challenges with clarity, speed, and measurable impact.
About us
A multi-capability commercial partner, intentionally built
We were built with a clear vision: to create a partner for life science leaders that enables clearer, braver commercialization decisions unlocking the full potential of their medicines and innovations.
By integrating five specialty firms with proven success across disciplines, therapeutic areas, and geographies, we created a global partner that understands your assets, your organization, and the realities you face.
Partnering from early development through launch and beyond, we reframe what’s possible by connecting insights across the asset lifecycle to align medical, access, insights, patient, and commercial strategy into one coordinated path forward.
Depth where it matters. Connection where it counts.
One accountable partner, built to deliver results.
Expertise
Integrated life sciences expertise across the product lifecycle
In complex environments, progress doesn’t come from following the same playbook. It comes from seeing differently.
Acumetis brings senior experts across medical, access, commercial, evidence, and patient disciplines together to:
- Challenge entrenched assumptions
- Surface blind spots others miss
- Connect fragmented data into decision-ready insight
- Shape solutions that are innovative and practical
We combine diverse life sciences consulting experience with disciplined execution to reduce uncertainty, de-risk strategy, and accelerate performance, while improving outcomes for patients.
Commercial Strategy
Proven commercial leaders use actionable insight to uncover new angles and design solutions that strengthen operating models, brand performance, and long-term value.
Launch Excellence
Connected insights and practical innovation identify risks and opportunities, de-risking launch planning and execution to maximize uptake and access.
Patient Access & Support
Leveraging deep understanding of patient access landscapes we design and activate patient access and support programs that remove barriers, unite stakeholders and accelerate therapy adoption.
Global Value and Access
We integrate evidence strategy, health economics, and market access to define value, earn coverage, and drive adoption across key markets.
Insights & Analytics
By combining proprietary information platforms with therapeutic market experts, we deliver insights that translate into actionable advantage in rare disease landscapes.
Medical Affairs
Scientific acumen and therapeutic market insights shape compelling narratives that educate the market and drive informed behavior change.
Proven impact,
measurable results
0
+
Rare disease markets
covered by our proprietary information platforms providing insights and evidence not available elsewhere
0
+
HTA and payer submissions
in the last 5 years
0
+
Product launches
Experience that delivers a knowledge base that derisks decisions and drive outcomes
Resources
Insights, perspectives & resources
Solutions
Life science solutions built for decision quality
We integrate proprietary information platforms, diverse scientific and commercial expertise, analytics, modeling, and strategic intelligence so teams can move faster with rigor.
Model builder
Automate calculations, reduce errors, and collaborate globally to accelerate health economics and outcomes research across the therapy lifecycle. Our Acumetis Model Builder empowers life sciences teams to create accurate, HTA and payer-ready economic models in minutes, supporting pharmaceutical commercial strategy and market access.
Launch Catalyst
Built on 200+ launches and thousands of hours of real-world experience, our launch planning platform generates tailored, actionable plans aligned to your specific product and strategy. Identify risks early, navigate complexity with confidence, and execute with precision; our tool helps you and your team turn abstract planning into practical, high-quality launch execution.
NMA builder
Acumetis NMA Builder lets life sciences teams run complex network meta-analyses quickly, accurately, and without specialized statistical knowledge. With an intuitive interface, validated calculations, and robust reporting, it turns complex data into actionable insights for health economics, pharma commercial strategy, and market access decisions.